Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study

BMC Pediatr. 2018 Jun 11;18(1):189. doi: 10.1186/s12887-018-1163-2.

Abstract

Background: Erythema migrans (EM) is the most common manifestation of Lyme borreliosis (LB), caused by the spirochete Borrelia burgdorferi sensu lato. The infection can disseminate into the nervous system and cause Lyme neuroborreliosis (LNB), the second most frequent LB manifestation in children. The aim of this prospective cohort study is to describe the occurrence of EM among children with LNB and to evaluate possible differences in clinical characteristics or outcome between LNB patients with and without EM.

Method: Children being evaluated for LNB in southeast Sweden during the period 2010-2014 underwent a clinical examination, laboratory testing and filled out a questionnaire regarding duration and nature of symptoms, EM and the child's health. Children were classified according to European guidelines for LNB. Clinical recovery was evaluated at a 2-month follow-up.

Results: The occurrence of EM among children with LNB was 37 out of 103 (36%). Gender, age, observed tick bite, clinical features, duration of neurological symptoms or clinical outcome did not differ significantly between LNB patients with or without EM. However, facial nerve palsy was significantly more common among children with EM in the head and neck area.

Conclusion: EM occurred in 36% of children with LNB and the location on the head and neck was more common among children with facial nerve palsy. EM was not associated with other specific clinical characteristics or outcome. Thus, the occurrence of EM in children with LNB cannot be useful as a prognostic factor for clinical outcome. This aspect has not previously been highlighted but seems to be relevant for the paediatrician in a clinical setting.

Keywords: Children; Clinical outcome; Erythema migrans; Facial nerve palsy; Lyme neuroborreliosis.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Ceftriaxone / therapeutic use
  • Child
  • Child, Preschool
  • Doxycycline / therapeutic use
  • Erythema Chronicum Migrans / complications*
  • Erythema Chronicum Migrans / pathology
  • Facial Paralysis / etiology
  • Female
  • Head / pathology
  • Humans
  • Infant
  • Lyme Neuroborreliosis / complications*
  • Lyme Neuroborreliosis / drug therapy
  • Male
  • Neck / pathology
  • Prospective Studies
  • Sweden

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone
  • Doxycycline